日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multivariate analysis of prognostic factors in patients with nodular melanoma

结节性黑色素瘤患者预后因素的多变量分析

Susok, L; Stücker, M; Bechara, F G; Stockfleth, E; Gambichler, T

Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results

免疫检查点抑制剂治疗原发灶不明的黑色素瘤患者的疗效优于原发灶明确的黑色素瘤患者:初步结果

Gambichler, Thilo; Chatzipantazi, Maria; Schröter, Ulrike; Stockfleth, E; Gedik, Cansu

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

黑色素瘤患者在接受伊匹木单抗和纳武利尤单抗联合治疗后出现副肿瘤性白细胞增多症

Gambichler, Thilo; Stockfleth, E; Susok, L

Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure

德国人群中默克尔细胞癌左侧发病率较高:不仅仅是日晒的影响

Gambichler, T; Wieland, U; Silling, S; Dreißigacker, M; Schaller, J; Schulze, H-J; Oellig, F; Kreuter, A; Stücker, M; Bechara, F G; Stockfleth, E; Becker, J C

Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma

肿瘤血管生成和临床病理参数作为默克尔细胞癌的预后因素

Bob, A; Nielen, F; Krediet, J; Schmitter, J; Freundt, D; Terhorst, D; Röwert-Huber, J; Kanitakis, J; Stockfleth, E; Ulrich, Ch; Weichenthal, M; Egberts, F; Lange-Asschenfeldt, B

Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma.

高表达的 atonal 同源物-1 在默克尔细胞癌中的预后意义

Gambichler T, Mohtezebsade S, Wieland U, Silling S, Höh A-K, Dreißigacker M, Schaller J, Schulze H-J, Oellig F, Kreuter A, Stockfleth E, Stücker M, Bechara F G, Becker J C

Prevalence of antibodies to human papillomavirus type 8 in human sera

人血清中人乳头瘤病毒8型抗体的流行率

Steger, G; Olszewsky, M; Stockfleth, E; Pfister, H

Uniform Requirements for Manuscripts Submitted to Biomedical Journals

生物医学期刊投稿的统一要求

Ulrich, C; Bichel, J; Euvrard, S; Guidi, B; Proby, C M; van de Kerkhof, P C M; Amerio, P; Rønnevig, J; Slade, H B; Stockfleth, E